Neovasc to Report Second Quarter 2021 Financial Results on August 10, 2021
July 27 2021 - 9:05AM
via NewMediaWire -- Neovasc Inc. (NASDAQ, TSX:
NVCN), will report financial results for the second quarter ended
June 30, 2021 on Tuesday, August 10 2021. Neovasc’s President
and Chief Executive Officer, Fred Colen, and Chris Clark, Chief
Financial Officer, will host a conference call to review the
Company’s results at 4:30 pm EDT.
Interested parties may access the conference call
by dialing (877)-407-9208 or (201)-493-6784 (International) and
reference Conference ID 13721306. Participants wishing to join the
call via webcast should use the link posted on the investor
relations section of the Neovasc website
at https://www.neovasc.com/investors/.
A replay of the webcast will be available
approximately 30 minutes after the conclusion of the call using the
link on the Neovasc
website.
About Neovasc Inc.
Neovasc is a specialty medical device company that
develops, manufactures and markets products for the rapidly growing
cardiovascular marketplace. The Company is a leader in the
development of minimally invasive transcatheter mitral valve
replacement technologies, and minimally invasive devices for the
treatment of refractory angina. Its products include the Neovasc
Reducer™, for the treatment of refractory angina, which is not
currently commercially available in the United States (2 U.S.
patients have been treated under Compassionate Use) and has been
commercially available in Europe since 2015, and Tiara™, for the
transcatheter treatment of mitral valve disease, which is currently
under clinical investigation in the United States, Canada, Israel
and Europe. For more information,
visit: www.neovasc.com.
Investors
Mike Cavanaugh
Westwicke/ICR
Phone: +1.646.877.9641
Mike.Cavanaugh@westwicke.com
Media
Sean Leous
Westwicke/ICR
Phone: +1.646.866.4012
Sean.Leous@icrinc.com
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Apr 2023 to Apr 2024